Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ATRA.NASDAQ

Atara Biotherapeutics Inc (ATRA NASDAQ) stock market data APIs

$9.67 -0.5(-4.9%) as of July 26, 2024
Price chart is built with Anychart

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA3219, currently in Phase 1 trials, as well as ATA3431, under preclinical trials for the treatment of B-cell malignancies and autoimmune diseases; and ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Atara Biotherapeutics Inc Financial Data Overview

10.17
9.67
-
10.18
9.67
4.965-63.375
47 866 K
4 904 K
34 704 K
-0.23
0.517
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ATRA',
Type: 'Common Stock',
Name: 'Atara Biotherapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG005Q3MQY4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1604464',
EmployerIdNumber: '46-0920988',
FiscalYearEnd: 'December',
IPODate: '2014-10-16',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Atara Biotherapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 34 704 K
  • EBITDA -215 792 992
  • Earnings Per Share -53
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Atara Biotherapeutics Inc Earnings via APIs

  • Latest Release 2024-06-10
  • EPS/Forecast -0.26

Get Atara Biotherapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Atara Biotherapeutics Inc latest news via APIs

Seth Klarman's Exit from Atara Biotherapeutics Inc

Overview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction Warning! GuruFocus has detected 7 Warning Signs with ATRA. Renowned value investor Seth Klarman (Trades, Portfolio), through T...

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Overview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction Warning! GuruFocus has detected 7 Warning Signs with ATRA. Renowned value investor Seth Klarman (Trades, Portfolio), through T...
Do you have any questions?
support@eodhistoricaldata.com